Group 1 - The successful listing of Paige Biopharmaceuticals (Hangzhou) Co., Ltd. on the Hong Kong Stock Exchange marks the first listed company in the Gongshu District for 2025 and the first from the Fengqi Smart Innovation Ecosystem in Dongxin Street [1] - In the first quarter of this year, Dongxin Street achieved a retail sales revenue of 1.403 billion yuan, representing a year-on-year growth of 26.44%, with six key indicators ranking at the top of Gongshu District [1] - Paige Biopharmaceuticals, established in 2008, focuses on innovative therapies for chronic diseases and has received national support for major new drug creation projects [1] Group 2 - Dongxin Street has attracted several high-quality enterprises, including Ruile Biotechnology and Jiuyizhongli Medical, contributing to the development of related companies [2] - The Fengqi Smart Innovation Ecosystem aims to create a significant life and health industry cluster around the North City Sports Park, with a focus on collaboration between universities and innovation enterprises [2] - The ecosystem has established a development pattern of "one valley, two institutes, and five platforms," facilitating cooperation between innovation enterprises and renowned universities [2] Group 3 - Dongxin Street promotes collaboration between local industrial parks and Zhejiang University to create a comprehensive incubation system [3] - The area has attracted 21 full-time PhDs this year through partnerships with research institutes [3] - Eleven projects, including high-end equipment for vanadium electrolyte continuous electrolysis, have been implemented in the region [3]
东新环高校创新生态圈迎来首家上市企业